SIGA Technologies, Inc. (SIGA), a company specializing in the development of pharmaceutical agents, announced the appointment of the company’s Chief Executive Officer, Dr. Eric Rose, to serve as an inaugural member of the newly formed National Biodefense Science Board [NBSB].

The NBSB was created through the guidance of the Pandemic and All-Hazards Preparedness Act, initially constructed in December 2006. The NBSB seeks to provide expert advice and guidance to the Secretary of the Department of Health and Human Services regarding activities to prevent, prepare for and respond to adverse health effects of public health emergencies. These health emergencies can arise through chemical, biological, nuclear and radiological agent contamination; whether occurring in a natural manner, accidental manner, or deliberate manner.

Dr. Rose stated, “It is an honor for me to be asked to serve on a board that seeks to inform and assist HHS in its decision making processes surrounding preparedness and emergency response planning. I look forward to being an active contributor and will bring to bear any experience I can in assisting the board to make positive ongoing advisory contributions to the health and safety of the nation.”

Let us hear your thoughts below: